90. 網膜色素変性症 Retinitis pigmentosa Clinical trials / Disease details
臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05413148 (ClinicalTrials.gov) | August 5, 2022 | 28/5/2022 | The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa | The Effect of Wharton Jelly-derived Mesenchymal Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa | Retinitis Pigmentosa | Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cells;Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes;Other: Placebo | TC Erciyes University | NULL | Recruiting | 18 Years | 70 Years | All | 135 | Phase 2/Phase 3 | Turkey |